An Alzheimer's disease drug from Athira Pharma has failed a Phase 2 clinical trial and the biotech has a surprising theory why. Athira says standard of care drugs Alzheimer's patients are already taking may diminish the effect of its small molecule and this finding could inform how the company proceeds with an ongoing Phase 3 clinical trial.
Webinar Date: July 20, 2022 Time: 2:00pm ET / 11:00am PT
This webinar discusses how a human-computer team takes advantage of the clinical expertise and complex problem-solving ability of humans for the more challenging clinical registry fields and the speed and accuracy of AI technology for the more straightforward fields. The result is more accurate, timely data for clinical registries and internal patient care projects.
Other topics discussed:
The strengths and limitations of AI
Why a human+computer approach to data mining yields the best results
How AI methods such as machine learning and natural language processing can standardize clinical registry data
How to make clinical registry data available in real time across hospital systems for patient care, quality initiatives, and other internal projects
Don't miss out on this valuable opportunity to meet and discuss the latest trends and opportunities. Don't miss your chance to save with the Super Early Bird Rate.
By Julianne Malveaux Thursday, June 23, 2022 2:22 AM
The Clarifying Remanufacturing to Protect Patient Safety Act was introduced by Reps. Scott Peters (D-CA), Kim Schrier (D-WA), and John Joyce (R- PA) to clarify the meaning of medical device remanufacturing and empower the FDA to educate company technicians so they know if they've crossed the line into a regulated activity.
Novartis is paying Precision Bio $75 million up front to begin a partnership aiming to develop in vivo gene-editing therapies for serious genetic blood disorders, such as sickle cell disease. One of the goals of the alliance is to make genetic medicines more globally accessible.
The speed of Covid-19 vaccine trials should inspire the pharmaceutical and medical device industries to accelerate its clinical testing, according to Shweta Maniar, Google Cloud's director for healthcare and life sciences. She argued that harnessing real-world data will make faster clinical trials achievable for all therapeutics and devices, possibly even eliminating the need to recruit a placebo arm.
The ability of healthcare providers to leverage accurate, sophisticated and timely diagnostic testing for infertility patients is a crucial part of the patient journey.
Providence spun out Advata two weeks ago, and the startup, which has 30 customers and 150 employees, sells a suite of insights-focused data software products designed to improve population health and revenue cycle management.
A veteran of GE Healthcare, Joe Gasque talks about how he's growing the company's niche position in the high-paced aesthetics industry, offering services to surgeons, practitioners, medical device and injectables manufacturers.
Replace the tedious manual resume screening process! Learn how AI frameworks and technology are streamlining the recruiter/candidate experience, resulting in healthcare industries hiring skilled and knowledgeable personnel quickly and effectively.
No comments